期刊文献+

Clinical significance of immunohistochemica study of P53 protein in colorectal carcinoma 被引量:3

Clinical significance of immunohistochemica study of P53 protein in colorectal carcinoma
下载PDF
导出
摘要 AIMS To determine the clinical significance of P53 protein ex-pression in colorectal carcinoma.METHODS The expression of P53 protein in 92 colorectal car-cinomas was examined using the monoclonal antibody PAb 1801.Correlation between P53 protein expression and prognosis in col-orectal carcinoma was analyzed using log-rank test.RESULTS The frequency of P53 protein expression was 57.61%,corresponding with Dukes’ staging.Analysis of survivordata demonstrated that the survival rate of colorectal carcinomawith positive P53 protein group was lower than that of negativeP53 protein group.CONCLUSIONS We conclude that the expression of P53 pro-tein is correlated with poor prognosis in colorectal carcinoma. AIMS To determine the clinical significance of P53 protein ex- pression in colorectal carcinoma. METHODS The expression of P53 protein in 92 colorectal car- cinomas was examined using the monoclonal antibody PAb 1801. Correlation between P53 protein expression and prognosis in col- orectal carcinoma was analyzed using log-rank test. RESULTS The frequency of P53 protein expression was 57. 61%,corresponding with Dukes' staging.Analysis of survivor data demonstrated that the survival rate of colorectal carcinoma with positive P53 protein group was lower than that of negative P53 protein group. CONCLUSIONS We conclude that the expression of P53 pro- tein is correlated with poor prognosis in colorectal carcinoma.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 1996年第1期25-26,共2页 世界胃肠病学杂志(英文版)
关键词 COLORECTAL NEOPLASMS ONCOGENES PROTEIN P53 IMMUNOHISTOCHEMISTRY colorectal neoplasms oncogenes protein P53 immunohistochemistry
  • 相关文献

参考文献14

  • 1Takahashi T,Nau MM,Chiba I,Birrer MJ,Rosenberg RK,Vinocour M,et al.P53:a frequent target for genetic abnormalities in lung cancer. Science . 1989
  • 2Marks JR,Davidoff AM,Kerns BJ,Humphrey PA,Pence JC,Dodge RK,et al.Overexpression and mutation of P53 in epithelial ovarian cancer. Cancer Research . 1991
  • 3Hollstein M,Sidransky D,Vogelstein B,Harris CC.P53 mutations in human cancers. Science . 1991
  • 4Davidoff AM,Herndon JE,Glover NS,Kerns BJ,Pence JC,Iglehart JD,et al.Relation between P53 overexpression and established prognostic factors in breast cancer. Journal of Surgery . 1991
  • 5Eliyahu D,Michalovitz D,Eliyahu S,Pinhasi-kimhi-O,Oren M.Wild type P53 can inhibit oncogene-mediated focus formation. Proceedings of the National Academy of Sciences of the United States of America . 1989
  • 6Mercer WE,Shields MT,Amin M,Sauve GJ,Appella E,Romano JW,et al.Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type P53. Proceedings of the National Academy of Sciences of the United States of America . 1990
  • 7Cunningham J,Lust JA,Schaid DJ,Bren GD,Carpenter HA,Rizza E,et al.Expression of P53 and 17p allelic loos in cclorectal carcinoma. Cancer Research . 1992
  • 8Bartek J,Bartkova J,Vojtesek B,Staskova Z,Rejthar A,Kovarik J,et al.Patterns of expresaion of the P53 tumor suppressor in human breast tissues and tumors in situ and in vitro. International Journal of Cancer . 1990
  • 9Finlay CA,Hinds PW,Levine AJ.The P53 proto-oncogene can act as a suppressor of transformation. Cell . 1989
  • 10Baker SJ,Markowitz S,Fearson FR,WillxonJK,Vngilstein B.Suppression of human colorectal carcinoma cell growth by wild-type P53. Science . 1990

共引文献2

同被引文献96

引证文献3

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部